Frequently Asked Questions

Lung cancer can develop due to both genetic predisposition and environmental factors. While smoking is the most important risk factor, individuals with a family history have a higher risk of developing the disease.

Passive smoking, air pollution, radon gas exposure, genetic mutations, and occupational chemical exposure can also cause lung cancer to develop in non-smokers.

Yes. Adenocarcinoma type is seen more frequently in women, and the disease is often diagnosed at an earlier stage. It is also thought that hormonal factors may affect the biology of the disease.

Although rare, lung cancer can also be seen in individuals under the age of 40. In this age group, genetic predisposition and environmental exposures are more prominent.

Computed tomography (CT), PET-CT, bronchoscopy, and biopsy are the most commonly used diagnostic methods. These tests make it possible to determine the type, spread, and stage of the tumor.

In lung cancers detected at an early stage, the chance of surgical treatment is high and survival rates increase significantly. For this reason, screening is of great importance in individuals in the risk group.

Surgery can generally be performed in stage 1 and stage 2 patients. In selected stage 3 patients, surgery may also be considered after multidisciplinary evaluation.

In the case of metastasis, the disease has spread to other organs of the body. Treatment is mostly carried out with systemic methods such as chemotherapy, targeted therapies, and immunotherapy.

No. The response to chemotherapy depends on the type of tumor, its genetic characteristics, and the patient’s general health condition. Some tumors may be resistant to chemotherapy.

Long-term remission can be achieved in some patients, but complete recovery is not possible in every patient. Immunotherapy is especially effective in tumors with certain biological characteristics.

Life expectancy depends on the stage, the type of tumor, and the response to treatment. In patients diagnosed at an early stage, 5-year survival rates can reach up to 60%.

Yes. There is a risk of recurrence after treatment. Therefore, regular doctor check-ups and imaging follow-ups are of vital importance.

Depending on the stage of the disease and the treatments applied, some patients may continue their working life. This situation must definitely be planned with a physician’s evaluation.

Completely quitting smoking, regular exercise, balanced nutrition, and keeping stress under control both improve quality of life and reduce the risk of recurrence.

Pain usually occurs in advanced stages when the tumor spreads to the chest wall or nerve tissues. This condition can be brought under control with appropriate pain treatments.

Scars formed after surgery or weight loss may cause aesthetic concerns. Psychological support helps this process to be managed more healthily.

A balanced diet rich in protein and energy is recommended. Support from a nutrition specialist is very beneficial in patients with loss of appetite.

Yes. Anxiety and depression are common. Psychological support increases the patient’s compliance with treatment and quality of life.

Quitting smoking increases the response to treatment, slows the progression of the disease, and reduces the risk of developing a second cancer.

Emotional support, accompanying the treatment process, and providing correct information strengthen the patient’s morale. It is also recommended that relatives receive psychological support when necessary.